Skip to main content

Animations

MJFF Publications

341 - 350 of 8826 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2022
  • 2021
  • 2022
  • 2020
  • 2022
  • 2023
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14737175.2021.1968298
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects
    Journal Name: Expert Review of Medical Devices
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/17434440.2021.1969913
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions
    Journal Name: Expert Opinion on Drug Safety
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14740338.2022.2069240
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Neuropathological evidence of body-first vs. brain-first Lewy body disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557
    Citation Count: 87
  • Summary Details
    RESTRICTED
    Title: Immune responses in the Parkinson's disease brain
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700
    Citation Count: 35
  • Treatment of Nonmotor Symptoms Associated with Parkinson Disease
    2020
    Summary Details
    RESTRICTED
    Title: Treatment of Nonmotor Symptoms Associated with Parkinson Disease
    Journal Name: Neurologic Clinics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ncl.2019.12.003
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: LRRK2 as a target for modulating immune system responses
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105724
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106296
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105687
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.